July 27, 2012
The Ministry of Health, Labor and Welfare (MHLW) reported package insert revisions and case reports based on which revisions were considered regarding three products including Mitsubishi Tanabe Pharma Corporation’s (MTPC) hepatitis C treatment Telavic 250 mg Tablet (telaprevir) in Pharmaceuticals...read more